Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지

mRNA Expression of Thrombospondin-1 and -2 in Severe Endometriosis Patients in Korean Women

중증 자궁내막증 환자의 내막에서 thrombospondin-1과 -2의 mRNA의 발현에 관한 연구

  • Hur, Sung Eun (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University) ;
  • Lee, Ji Young (Department of Obstetrics and Gynecology, ollege of Medicine, KonKuk University) ;
  • Moon, Hye-Sung (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University) ;
  • Chung, Hye Won (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University)
  • 허성은 (이화여자대학교 의과대학 산부인과학교실) ;
  • 이지영 (건국대학교 의과대학 산부인과학교실) ;
  • 문혜성 (이화여자대학교 의과대학 산부인과학교실) ;
  • 정혜원 (이화여자대학교 의과대학 산부인과학교실)
  • Published : 2005.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: We investigated the expression of TSP-1 and -2 in eutopic endometrium of advanced endometriosis and control patients. Methods: The 33 endometriosis patients and 32 controls were enrolled. Endometrial samples were obtained from 65 premenopausal women aged 29-44 years, undergoing laparoscopic surgery or hysterectomy for non-malignant lesions. Sufficient samples were collected from 33 patients with endometriosis stage III and IV and 32 controls without endometriosis confirmed by laparoscopic surgery. The mRNA expression from eutopic endometrium for TSP-1 and -2 were analyzed by RT-QC PCR. Results: The mRNAs of TSP-1 and -2 were expressed in eutopic endometrium from endometriosis and normal controls throughout the menstrual cycle. There were no significant differences in expression of TSP-1 and TSP-2 in eutopic endometrium between controls and endometriosis patients. Conclusion: Our results indicated that TSP-1 and -2 had no crucial role compared to other molecules in the regulation of angiogenesis. These findings also suggest that dysregulation of other angiogenic regulators would be concerned in pathophysiologic role in endometriosis development.

Keywords

Acknowledgement

Supported by : 한국과학재단

References

  1. Kennedy S. Is therea genetic basisto endometriosis? Semin Reprod Endocrinol 1997; 15:309-18 https://doi.org/10.1055/s-2008-1068761
  2. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-69
  3. Simpson JL, Elias S, Malinak LR, ButtramVC Jr. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980; 137: 327-31
  4. Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod Immunol 2003; 50: 48-59 https://doi.org/10.1034/j.1600-0897.2003.00042.x
  5. Iruela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulator and inhibitors. Thrombo Haemost 1997; 78: 672-7
  6. Li J, Zhou J, Tota B, Scalia G, Gattuso A. Regulating effects of vascular endothelial growth factor and ANG II on frog's pericardial stomata, mesothelium and angiogenesis. Chin Med Sci J 2001; 16: 23-8
  7. Bums PA, Wilson DJ. Angiogenesis mediated by metabolites is dependent on vascular endothelial growth factor (VEGF). Angiogenesis 2003; 6: 73-7 https://doi.org/10.1023/A:1025862731653
  8. Sandberg T, Ehinger A, Casslen B. Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor. J Clin Endocrinol Metab 2001; 86: 1724-30 https://doi.org/10.1210/jc.86.4.1724
  9. Jung SP, Siegrist B, Wang YZ, Wade MR, Anthony CT, Homick C, et al. Effect of human Angiostatin protein on human angiogenesis in vitro. Angiogenesis 2003; 6: 233-40 https://doi.org/10.1023/B:AGEN.0000021402.80291.42
  10. Folkman J. Endogenous angiogenesis inhibitors. APMIS 2004; 112: 496-507 https://doi.org/10.1111/j.1600-0463.2004.apm11207-0809.x
  11. Baenziger NL, Brodie GN, Majerus PW. A thrombinsensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971; 68: 240-243
  12. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V. The role of thrombospondin-l in human disease. J Surg Res 2004; 122: 135-42 https://doi.org/10.1016/j.jss.2004.05.015
  13. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998; 140: 419-30 https://doi.org/10.1083/jcb.140.2.419
  14. Kyriakides TR, Zhu YH, Yang Z, Bomstein P. The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 1998; 46: 1007-15 https://doi.org/10.1177/002215549804600904
  15. Kanda S, Shono T, Tomasini-Johansson B, Klint P, Saito Y. Role of thrombospondin-l-derived peptide, 4N1K, in FGF-2-induced angiogenesis. Exp Cell Res 1999; 252: 262-72 https://doi.org/10.1006/excr.1999.4622
  16. Iruela-Arispe ML, Bomstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 1991; 88: 5026-5030
  17. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1997; 67: 817-21 https://doi.org/10.1016/S0015-0282(97)81391-X
  18. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122: 262-3
  19. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, et al. Thrombospondin-l expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 1997; 89: 219-27 https://doi.org/10.1093/jnci/89.3.219
  20. Fontana A, Filleur S, Guglielmi J, Frappart L, BrunoBossio G, Boissier S, et al. Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int J Cancer 2005; 116: 686-91 https://doi.org/10.1002/ijc.20584
  21. Rege TA, Fears CY, Gladson CL. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy. Neuro-oncol 2005; 7: 106-21 https://doi.org/10.1215/S115285170400119X
  22. Zhang X, Galardi E, Duquette M, Delic M, Lawler J, Parangi S. Antiangiogenic treatent with the three thrombospondin-l type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model. Clin Cancer Res 2005; 11: 2337-44 https://doi.org/10.1158/1078-0432.CCR-04-1900
  23. Lawler J, Detrnar M. Tumor progression: the effects of thrombospondin-1 and -2 Int J Biochem Cell Biol 2004; 36: 1038-45 https://doi.org/10.1016/j.biocel.2004.01.008
  24. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004 Mar; 89: 1089-95 https://doi.org/10.1210/jc.2003-031406
  25. Taylor RN, Mueller MD. Anti-angiogenic treatment of endometriosis: biochemical aspects. Gynecol Obstet Invest 2004; 57: 54-6
  26. Nap AW, Dunselman GA, Griffioen AW, Mayo KH, Evers JL, Groothuis PG. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril 2005; 83: 793-5 https://doi.org/10.1016/j.fertnstert.2004.06.080
  27. Adams RH, Wilkinson GA, Weiss C, Die1la F, Gale NW, Deutsch U, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999; 13: 295-306 https://doi.org/10.1101/gad.13.3.295
  28. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-8 https://doi.org/10.1038/35025215
  29. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002; 99: 11205-112010
  30. Thurston G. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 2003; 314: 61-8 https://doi.org/10.1007/s00441-003-0749-6
  31. Harada H, Nakagawa K, Saito M, Kohno S, Nagato S, Furukawa K, et al. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells. Cancer Lett 2003; 191: 109-19 https://doi.org/10.1016/S0304-3835(02)00592-X